Remove tag market-data
article thumbnail

STAT+: Drugmaker raises the price of an old chemo medicine tenfold amid persistent shortages

STAT

Amid sporadic shortages of a drug that is essential in preparing patients for lifesaving, cancer-fighting treatments, one manufacturer has returned to the market — but is selling its medicine for 10 to 20 times the prices offered by the only other companies with available supplies. Continue to STAT+ to read the full story…

Dosage 101
article thumbnail

Electronic smart packaging market to value nearly $3b in 2033

European Pharmaceutical Review

A market report has identified that global demand for electronic smart packaging will reach $2.6 percent from 2023, according to the data. A largely addressable market means that there is continued interest in smart packaging worldwide. billion in 2033. This represents a compound annual growth rate (CAGR) of 15.4

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin

Roots Analysis

It is worth noting that smart labels contain a transponder code which can be read by sophisticated devices, including radio frequency identification device (RFID) tags and near-field communication (NFC) chips. While most smartphones can read NFC chips, RFID tags can only be read by specialized receivers.

article thumbnail

Oligonucleotide synthesis market to reach $16.7 billion by 2027

European Pharmaceutical Review

According to a new market report by ResearchAndMarkets, the global oligonucleotide synthesis market is projected to reach $16.7 According to the report data, in 2021, antisense oligos accounted for the largest share of this segment, since many of these therapies are currently in clinical trials. Tag Copenhagen A/S (Denmark).

article thumbnail

Benefits of blockchain in limiting counterfeit drug distribution

European Pharmaceutical Review

While the counterfeit market is estimated to be a market of over $200 billion and despite its benefits, blockchain technology has not been fully implemented in the pharmaceutical supply chain, according to the paper. This can reduce the willingness for counterfeit and less accurate data, according to the review.

85
article thumbnail

Biogen, Eisai Alzheimer’s drug lecanemab fast tracked by FDA

pharmaphorum

The anti-amyloid drug, which also claimed a breakthrough tag from the FDA in July, is being developed for the treatment of early-stage Alzheimer’s disease. The $56,000-a-year price tag for the drug, which has now been cut in half in the US, also hasn’t helped the drugmakers make a case for Aduhelm with US payers.

FDA 111
article thumbnail

The pharmaceutical industry found it easier to fill artificial intelligence vacancies in Q3 2022

Pharmaceutical Technology

Artificial intelligence is one of the topics that GlobalData, our parent company and from whom the data for this article is taken, have identified as being a key disruptive technology force facing companies in the coming years. less time on average compared to similar jobs across the entire jobs market.

84